Major Events - Tianye Water Saving (00840) controlling shareholder Tianye Group plans to establish Xinjiang Tianze Water Conservancy Investment Development Co., Ltd. with the Eighth Division State-owned Assets Supervision and Administration Commission [1] - Chow Tai Fook Pharmaceutical (00013) and Innovent Biologics (01801) announced that the new drug application for Fucatinib combined with Sintilimab for the treatment of advanced renal cell carcinoma has been accepted in China [1] - CanSino Biologics (09926): The National Medical Products Administration approved the new indication application for the first-line treatment of cervical cancer for Katanib® (Cadonilimab, PD-1/CTLA-4) [1] - China National Pharmaceutical Group (01177): Phase III study data for Bemarituzumab combined or not combined with Anlotinib for consolidating treatment of non-small cell lung cancer after chemoradiotherapy will be announced at the 2025 ASCO annual meeting [1] - Baidu Biotechnology-B (02315) RenMab technology platform has received a new patent authorization in Japan, continuing to deepen the global patent layout of RenMice fully human antibodies/TCR platform [1] - Heng Rui Medicine (01276): Sodium citrate blood filtration replacement solution has been approved for marketing [1] - Shandong Xinhua Pharmaceutical (00719) obtained drug registration certificates for injectable Isavuconazole and Eicosapentaenoic acid ethyl ester soft capsules [1] - Stone Pharmaceutical Group (01093): Adenosylcobalamin capsules received drug registration approval [1] - Youjia Innovation (02431) reached a cooperation with Changan Automobile, securing a key model for its new energy self-owned brand [1] - Qiu Tai Technology (01478) completed a private placement of Norwegian listed company poLight, becoming its largest single shareholder, focusing on XR and robotics optics [1] Operating Performance - Hongyang Real Estate (01996) reported a cumulative contract sales amount of 2.47 billion yuan in the first five months, a year-on-year decrease of 39.77% [1] - Jingrui Holdings (01862) reported a contract signed sales amount of approximately 387 million yuan in the first five months, a year-on-year decline of 50.76% [1] - Dailisi International (00333) reported a year-on-year increase in sales revenue of 16.8% to 947 million HKD in the first three quarters [1] - Sunac China (01918) achieved a contract sales amount of approximately 16 billion yuan in the first five months, a year-on-year decrease of 35.28% [1] - Zhengrong Real Estate (06158) reported a cumulative contract sales amount of approximately 1.963 billion yuan in the first five months, a year-on-year decrease of 30.64% [1] - Greentown China (03900) reported a total contract sales amount of approximately 96.5 billion yuan in the first five months, a year-on-year decline of 2.3% [1] - Dongfeng Motor Group (00489) reported cumulative automobile sales of 672,800 units in the first five months, a year-on-year decrease of approximately 17.1% [1]